Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia: Significance of acetylcarnitine determination to estimate the proper carnitine dose

Tamiko Itoh, Tetsuya Ito, Satoru Ohba, Naruji Sugiyama, Kouhei Mizuguchi, Seiji Yamaguchi, Kiyoshi Kidouchi

研究成果: Article

12 引用 (Scopus)

抄録

In isovaleric acidemia (IVA), accumulated isovaleryl-CoA in the mitochondrion induces variable metabolic disturbances. To remove intramitochondrial isovaleryl groups, glycine therapy has been advocated primarily. On the other hand, secondary carnitine deficiency has been documented in this disorder and carnitine supplementation alone has been reported to be effective. In the present study, we administered carnitine and glycine to patients with IVA and investigated serum carnitine and urinary excretion of total and free carnitine, acylcarnitine profile (i.e., isovalerylcarnitine and acetylcarnitine), and isovalerylglycine. By adding carnitine to glycine supplementation, more isovalerylglycine, not only isovalerylcarnitine, was excreted in the urine. Acetylcarnitine was detected in the urine only when sufficient carnitine was supplemented. We concluded that combined therapy of glycine and carnitine is more effective and safer to eliminate isovaleryl-CoA in IVA than conventional therapy using either glycine or carnitine. Urinary acetylcarnitine concentration might be a good marker indicating the optimal dose of L-carnitine supplementation.

元の言語English
ページ(範囲)101-109
ページ数9
ジャーナルTohoku Journal of Experimental Medicine
179
発行部数2
DOI
出版物ステータスPublished - 01-01-1996
外部発表Yes

Fingerprint

Acetylcarnitine
Carnitine
Metabolism
Glycine
Isovaleric acidemia
Urine
Mitochondria
Group Psychotherapy

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

これを引用

Itoh, Tamiko ; Ito, Tetsuya ; Ohba, Satoru ; Sugiyama, Naruji ; Mizuguchi, Kouhei ; Yamaguchi, Seiji ; Kidouchi, Kiyoshi. / Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia : Significance of acetylcarnitine determination to estimate the proper carnitine dose. :: Tohoku Journal of Experimental Medicine. 1996 ; 巻 179, 番号 2. pp. 101-109.
@article{dd713e2bb6f0440dba878fed9f320b42,
title = "Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia: Significance of acetylcarnitine determination to estimate the proper carnitine dose",
abstract = "In isovaleric acidemia (IVA), accumulated isovaleryl-CoA in the mitochondrion induces variable metabolic disturbances. To remove intramitochondrial isovaleryl groups, glycine therapy has been advocated primarily. On the other hand, secondary carnitine deficiency has been documented in this disorder and carnitine supplementation alone has been reported to be effective. In the present study, we administered carnitine and glycine to patients with IVA and investigated serum carnitine and urinary excretion of total and free carnitine, acylcarnitine profile (i.e., isovalerylcarnitine and acetylcarnitine), and isovalerylglycine. By adding carnitine to glycine supplementation, more isovalerylglycine, not only isovalerylcarnitine, was excreted in the urine. Acetylcarnitine was detected in the urine only when sufficient carnitine was supplemented. We concluded that combined therapy of glycine and carnitine is more effective and safer to eliminate isovaleryl-CoA in IVA than conventional therapy using either glycine or carnitine. Urinary acetylcarnitine concentration might be a good marker indicating the optimal dose of L-carnitine supplementation.",
author = "Tamiko Itoh and Tetsuya Ito and Satoru Ohba and Naruji Sugiyama and Kouhei Mizuguchi and Seiji Yamaguchi and Kiyoshi Kidouchi",
year = "1996",
month = "1",
day = "1",
doi = "10.1620/tjem.179.101",
language = "English",
volume = "179",
pages = "101--109",
journal = "Tohoku Journal of Experimental Medicine",
issn = "0040-8727",
publisher = "Tohoku University Medical Press",
number = "2",

}

Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia : Significance of acetylcarnitine determination to estimate the proper carnitine dose. / Itoh, Tamiko; Ito, Tetsuya; Ohba, Satoru; Sugiyama, Naruji; Mizuguchi, Kouhei; Yamaguchi, Seiji; Kidouchi, Kiyoshi.

:: Tohoku Journal of Experimental Medicine, 巻 179, 番号 2, 01.01.1996, p. 101-109.

研究成果: Article

TY - JOUR

T1 - Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia

T2 - Significance of acetylcarnitine determination to estimate the proper carnitine dose

AU - Itoh, Tamiko

AU - Ito, Tetsuya

AU - Ohba, Satoru

AU - Sugiyama, Naruji

AU - Mizuguchi, Kouhei

AU - Yamaguchi, Seiji

AU - Kidouchi, Kiyoshi

PY - 1996/1/1

Y1 - 1996/1/1

N2 - In isovaleric acidemia (IVA), accumulated isovaleryl-CoA in the mitochondrion induces variable metabolic disturbances. To remove intramitochondrial isovaleryl groups, glycine therapy has been advocated primarily. On the other hand, secondary carnitine deficiency has been documented in this disorder and carnitine supplementation alone has been reported to be effective. In the present study, we administered carnitine and glycine to patients with IVA and investigated serum carnitine and urinary excretion of total and free carnitine, acylcarnitine profile (i.e., isovalerylcarnitine and acetylcarnitine), and isovalerylglycine. By adding carnitine to glycine supplementation, more isovalerylglycine, not only isovalerylcarnitine, was excreted in the urine. Acetylcarnitine was detected in the urine only when sufficient carnitine was supplemented. We concluded that combined therapy of glycine and carnitine is more effective and safer to eliminate isovaleryl-CoA in IVA than conventional therapy using either glycine or carnitine. Urinary acetylcarnitine concentration might be a good marker indicating the optimal dose of L-carnitine supplementation.

AB - In isovaleric acidemia (IVA), accumulated isovaleryl-CoA in the mitochondrion induces variable metabolic disturbances. To remove intramitochondrial isovaleryl groups, glycine therapy has been advocated primarily. On the other hand, secondary carnitine deficiency has been documented in this disorder and carnitine supplementation alone has been reported to be effective. In the present study, we administered carnitine and glycine to patients with IVA and investigated serum carnitine and urinary excretion of total and free carnitine, acylcarnitine profile (i.e., isovalerylcarnitine and acetylcarnitine), and isovalerylglycine. By adding carnitine to glycine supplementation, more isovalerylglycine, not only isovalerylcarnitine, was excreted in the urine. Acetylcarnitine was detected in the urine only when sufficient carnitine was supplemented. We concluded that combined therapy of glycine and carnitine is more effective and safer to eliminate isovaleryl-CoA in IVA than conventional therapy using either glycine or carnitine. Urinary acetylcarnitine concentration might be a good marker indicating the optimal dose of L-carnitine supplementation.

UR - http://www.scopus.com/inward/record.url?scp=0029838593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029838593&partnerID=8YFLogxK

U2 - 10.1620/tjem.179.101

DO - 10.1620/tjem.179.101

M3 - Article

C2 - 8875766

AN - SCOPUS:0029838593

VL - 179

SP - 101

EP - 109

JO - Tohoku Journal of Experimental Medicine

JF - Tohoku Journal of Experimental Medicine

SN - 0040-8727

IS - 2

ER -